3Bridgewater JA,Neistrop AE,Rustin GJ,et al,Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel[J].J Clin Oncol,1999,17(2):501-508. 被引量：1
4Tsuda H,Hashiguchi Y,Nakata S,et al,The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer[J].IntJ Gynecol Cancer,2002,12(5):435-437. 被引量：1
5Riedinger JM,Bonnetain F,Basuyau JP,et al,Change in CA 125levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian turnout outcome[J].Ann Oncol,2007,18(5):881-885. 被引量：1
6Markman M,Federico M,Liu PY,et al,Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer[J].Gynecol Oncol,2006,103(1):195-198. 被引量：1
7Krivak TG,Tian C,Rose GS,et al.A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage Ⅲ optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy:an analysis of patients enrolled in GOG 172[J].Gynecol Oncol,2009,115(1):81-85. 被引量：1
8Markman M,Liu PY,Rothenberg ML,et al.Pretreatment CA-125 and risk of relapse in advanced ovarian cancer[J].J Clin Oncol,2006,24(9):1454-1458. 被引量：1
9Rocconi RP,Matthews KS,Kemper MK,et al.The timing of normalization of GA-125 levels during primary chemotherapy is predictive of survival in patients with epithelial ovarian cancer[J].Gynecol Oncol,2009,114(2):242-245. 被引量：1
10Crawford SM,Peace J.Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary[J] ? Ann Oncol,2005,16(1):47-50. 被引量：1
